摘要
目的:以牦牛乳源酪蛋白为原料,利用瑞士乳杆菌,对发酵法制备降血压肽的工艺进行初步探讨.方法:试验首先采用凝乳酶沉淀法从牦牛乳中提取酪蛋白,依据瑞士乳杆菌的发酵特点,按5%(体积比)接菌量进行发酵制备降血压肽.然后并以降血压肽对血管紧张素转换酶(ACE)的抑制率为指标,主要探讨了底物浓度、pH值、发酵时间三因素对瑞士乳杆菌发酵法制备降血压肽工艺的影响.结果:在接菌量为5%,其他三因素各设置五个水平进行工艺优化,最优工艺条件为:底物浓度4%、发酵pH值8.0、发酵时间16 h.此工艺条件下ACE抑制率可达约68%.结论:通过实验说明底物浓度、pH值、发酵时间等参数的控制对发酵酪蛋白制备抑制肽很重要,此试验数据为后续进一步完善制备降血压肽的实验奠定了重要的基础.
Objective: Yak Casein and Lactobacillus helveticus as raw material, the preparation process of antihypertensive peptides using fermentation method was discussed. Methods: Firstly we extracted casein from yak milk using rennet precipitation method, and preparated antihypertensive peptides of fermentation using 5 % (volume ratio) inoculation amount according to the fermentation characteristics of Lactobacillus helveticus.Then inhibitory rate of antihypertensive peptides to angiotensin- converting enzyme ACE) as indicators, we mainly discussed the influence of the substrate concentration, pH value, the fermentation time to antihypertensive peptides preparation of fermentation method. Results: While the inoculums was 5 %, other three factors of each set five levels to process optimization, the optimum conditions as follows: substrate concentration was 4 % pH value of fermentation was 8.0, the fermentation time was 16h. The ACE inhibition rate was almost to 68 % in this condition. Conclusion: the control of substrate concentration, pH value, the time of fermentation and other parameters are very important to preparation of antihypertensive peptides. This experimental test data laid an important foundation for further preparation of antihypertensive peptides more efficiently.
出处
《西北民族大学学报(自然科学版)》
2013年第2期64-71,共8页
Journal of Northwest Minzu University(Natural Science)
基金
甘肃省农业生物技术研究与应用开发项目<牦牛乳源降血压肽和水解乳蛋白制备工艺技术研究与开发>(GNSW-2011-17)
校地合作项目<牦牛乳的综合开发与利用>(XBMU-2011-BC-42)
甘肃省科技支撑计划项目<水解乳蛋白的制备及产业化>(2010-147号)
关键词
瑞士乳杆菌
降血压肽
血管紧张素转化酶(ACE)
ACE抑制肽
Lactobacillus helveticus
Antihypertensive
peptides
Angiotensin - converting enzyme (ACE)
ACE inhibitory peptides